Mike, If I thought Onko Sure was a good product, I would probably own the stock but I know way too much about Universal Cancer markers to have any faith in the product.
I do agree that it can be used to help monitor CRC but even then, it does not do a great job. It misses 26% of the critical situations where the cancer is growing and the test errors. In the literature in the FDA approval, it states that the test can vary as much as 15% from day to day. The basis of FDA approval was an increase of over 15% from the previous test.
As a general screening tool, it is a joke. The false positives are huge and the company even admitted it during a conference call. What use are they pushing for international sales... Screening? It will fail just as it did back in 2001.
I would caution everyone to read the SEC filings. Ignore the hype by bloggers and the ridiculous estimates of sales given by the company. They have never even come within 10% of the estimates. The bloggers have turned a $10 million estimated sales potential into a $10 million order. That is how ridiculous the hype is.
News 
Market Data 
Discover 
